The Indian Journal of Pediatrics

, Volume 80, Supplement 1, pp 48–54 | Cite as

The Clinical Treatment of Childhood Obesity

  • Diana H. Dolinsky
  • Sarah C. Armstrong
  • Sanjay Kinra
Symposium on Chronic NONCOMMUNICABLE Diseases and Children

Abstract

With the rising prevalence of childhood obesity, pediatricians are increasingly called upon to treat clinically overweight children. The primary treatment options are behavioral lifestyle modification, pharmacotherapy, and surgery. The cornerstone of childhood obesity treatment is lifestyle modification and has been shown to be effective in improving the severity of overweight and obesity. Several guidelines discuss appropriate methods for lifestyle modification in overweight and obese children. This review will summarize three recent guidelines/recommendations (released by the Scottish Intercollegiate Network, the American Academy of Pediatrics, and the United Kingdom National Institute for Health and Clinical Excellence) and describe by way of example, a current child obesity treatment program in the United States (Duke University Medical Center). Finally, evidence for pharmacologic and surgical treatment options will also be discussed, which can be valuable treatment options for select patients.

Keywords

Overweight Childhood obesity Treatment Lifestyle 

References

  1. 1.
    Raj M, Kumar RK. Obesity in children & adolescents. Indian J Med Res. 2010;132:598–607.PubMedGoogle Scholar
  2. 2.
    Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics. 1998;101:518–25.PubMedGoogle Scholar
  3. 3.
    Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of child and adolescent overweight and obesity. Pediatrics. 2007;120:S193–228.PubMedCrossRefGoogle Scholar
  4. 4.
    Whitlock EP, O’Connor EA, Williams SB, Beil TL, Lutz KW. Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF. Pediatrics. 2010;125:e396–418.PubMedCrossRefGoogle Scholar
  5. 5.
    National Institute for Health and Clinical Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. London 2006.http://guidance.nice.org.uk/CG43/Guidance/Section. Accessed 06 Oct 2011.
  6. 6.
    Scottish Intercollegiate Guidelines Network. Management of Obesity: A national clinical guideline. Edinburgh 2010.http://www.sign.ac.uk/pdf/sign115.pdf. Accessed 06 Oct 2011.
  7. 7.
    Spear BA, Barlow SE, Ervin C, et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics. 2007;120:S254–88.PubMedCrossRefGoogle Scholar
  8. 8.
    Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E; Obesity Canada Clinical Practice Guidelines Expert Panel. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ. 2007;176:S1–13.PubMedGoogle Scholar
  9. 9.
    Australian National Health and Medical Research Council. Clinical Practice Guidelines for the Management of Overweight and Obesity in Children and Adolescents. Canberra 2003.http://www.health.gov.au/internet/main/publishing.nsf/Content/obesityguidelines-guidelines-children.htm. Accessed 06 Oct 2011.
  10. 10.
    Miller WR, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002.Google Scholar
  11. 11.
    August GP, Caprio S, Fennoy I, et al; Endocrine Society. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93:4576–99.PubMedCrossRefGoogle Scholar
  12. 12.
    Pollack A. Abott Labs Withdraws Meridia From the Market. The New York Times. 2010 October 8;Sect. B3.http://www.nytimes.com/2010/10/09/health/09drug.html. Acccessed 06 Oct 2011.
  13. 13.
    Iughetti L, China M, Berri R, Predieri B. Pharmacological treatment of obesity in children and adolescents: present and future. J Obes. 2011;2011:928165.PubMedGoogle Scholar
  14. 14.
    Viner RM, Hsia Y, Tomsic T, Wong IC. Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis. Obes Rev. 2010;11:593–602.PubMedCrossRefGoogle Scholar
  15. 15.
    Woo J, Sea MM, Tong P, et al. Effectiveness of a lifestyle modification programme in weight maintenance in obese subjects after cessation of treatment with Orlistat. J Eval Clin Pract. 2007;13:853–9.PubMedGoogle Scholar
  16. 16.
    Park MH, Kinra S, Ward KJ, White B, Viner RM. Metformin for obesity in children and adolescents: a systematic review. Diabetes Care. 2009;32:1743–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Yanovski JA, Krakoff J, Salaita CG, et al. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes. 2011;60:477–85.PubMedCrossRefGoogle Scholar
  18. 18.
    Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (Lond). 2007;31:1–14.CrossRefGoogle Scholar
  19. 19.
    Treadwell JR, Sun F, Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg. 2008;248:763–76.PubMedCrossRefGoogle Scholar
  20. 20.
    Pratt JS, Lenders CM, Dionne EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring). 2009;17:901–10.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2012

Authors and Affiliations

  • Diana H. Dolinsky
    • 1
  • Sarah C. Armstrong
    • 1
  • Sanjay Kinra
    • 2
    • 3
  1. 1.Department of PediatricsDuke UniversityDurhamUSA
  2. 2.Department of Non-Communicable Disease EpidemiologyLondon School of Hygiene and Tropical MedicineLondonUK
  3. 3.Child and Adolescent DivisionUniversity College London Hospitals NHS Foundation TrustLondonUK

Personalised recommendations